Endometrial carcinoma expresses an increased cathepsin B/D ratio

Gynecologic Oncology

Volumn 108, Issue 1, 2008, Pages 84-89

  Bradley, William H ^a   Lima, Paul H ^b   Rodgers, Lisa ^b   Blomquist, Charles H ^b   Downs, Levi S ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cathepsin B; Cathepsin D; Endometrial Carcinoma

Indexed keywords

CATHEPSIN B; CATHEPSIN D;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SPECIFICITY; FEMALE; FLUOROMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

CATHEPSIN B; CATHEPSIN D; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING;

EID: 37449016836     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.08.094     Document Type: Article

References (28)

1. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 10 (1994) 31-46
2. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 106 (2005) 413-425
3. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
4. Trope C., Alektiar K.M., Sabbatini P.J., and Zaino R.J. Principals and Practice of Gynecologic Oncology (2004)
5. Kos J., and Lah T.T. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol Rep 5 (1998) 1349-1361
6. Lah T.T., and Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol Chem 379 (1998) 125-130
7. Roshy S., Sloane B.F., and Moin K. Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev 22 (2003) 271-286
8. Gohring U.J., Scharl A., Thelen U., Ahr A., Crombach G., and Titius B.R. Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods. J Clin Pathol 49 (1996) 57-64
9. Wolf M., Clark-Lewis I., Buri C., Langen H., Lis M., and Mazzucchelli L. Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer. Am J Pathol 162 (2003) 1183-1190
10. Adenis A., Huet G., Zerimech F., Hecquet B., Balduyck M., and Peyrat J.P. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. Cancer Lett 96 (1995) 267-275
11. Ebert W., Knoch H., Werle B., Trefz G., Muley T., and Spiess E. Prognostic value of increased lung tumor tissue cathepsin B. Anticancer Res 14 (1994) 895-899
12. Chung S.M., and Kawai K. Protease activities in gastric cancer tissues. Clin Chim Acta 189 (1990) 205-210
13. Terada T., Ohta T., Minato H., and Nakanuma Y. Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomas. Hum Pathol 26 (1995) 746-752
14. Losch A., Kohlberger P., Gitsch G., Kaider A., Breitenecker G., and Kainz C. Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. Br J Cancer 73 (1996) 1525-1528
15. Falcon O., Chirino R., Leon L., Lopez-Bonilla A., Torres S., Fernandez L., et al. Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer. Br J Cancer 79 (1999) 570-576
16. Maudelonde T., Martinez P., Brouillet J.P., Laffargue F., Pages A., and Rochefort H. Cathepsin-D in human endometrium: induction by progesterone and potential value as a tumor marker. J Clin Endocrinol Metab 70 (1990) 115-121
17. Saygili U., Koyuncuoglu M., Altunyurt S., Guclu S., Uslu T., and Erten O. May cathepsin D immunoreactivity be used as a prognostic factor in endometrial carcinomas? A comparative immunohistochemical study. Gynecol Oncol 83 (2001) 20-24
18. Scambia G., Benedetti Panici P., Ferrandina G., Distefano M., Romanini M.E., Sica G., et al. Significance of cathepsin-D expression in uterine tumours. Eur J Cancer 31A (1995) 1449-1454
19. Pagano M., Capony F., and Rochefort H. Pro-cathepsin D can activate in vitro pro-cathepsin B secreted by ovarian cancers. C R Acad Sci III 309 (1989) 7-12
20. Sinha A.A., Quast B.J., Wilson M.J., Fernandes E.T., Reddy P.K., Ewing S.L., and Gleason D.F. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma. Cancer 94 (2002) 3141-3149
21. Sinha A.A., Quast B.J., Wilson M.J., Fernandes E.T., Reddy P.K., Ewing S.L., et al. Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer. Prostate 48 (2001) 274-284
22. Barrett A.J. Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. Biochem J 187 (1980) 909-912
23. Barrett A.J., and Kirschke H. Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol 80 Pt C (1981) 535-561
24. Gulnik S.V., Suvorov L.I., Majer P., Collins J., Kane B.P., Johnson D.G., et al. Design of sensitive fluorogenic substrates for human cathepsin D. FEBS Lett 413 (1997) 379-384
25. Labarca C., and Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102 (1980) 344-352
26. Markwell M.A., Haas S.M., Tolbert N.E., and Bieber L.L. Protein determination in membrane and lipoprotein samples: manual and automated procedures. Methods Enzymol 72 (1981) 296-303
27. Mylonas I., Makovitzky J., Richter D.U., Jeschke U., Briese V., and Friese K. Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Acta Histochem 105 (2003) 245-252
28. Downs Jr. L.S., Lima P.H., Bliss R.L., and Blomquist C.H. Cathepsins B and D activity and activity ratios in normal ovaries, benign ovarian neoplasms, and epithelial ovarian cancer. J Soc Gynecol Investig 12 (2005) 539-544